China Sets Up Committee For Pharmaceutical Research Intellectual Property Rights
This article was originally published in PharmAsia News
Executive Summary
Chinese Pharmaceutical Association's Committee for Pharmaceutical Research Intellectual Property Rights, the first professional organization in the field, recently held its first plenary meeting in Beijing. The committee was set up with the objectives of bridging communication among authorities, societies, pharmaceutical enterprises and public institutions; providing advice on IP rights strategy for the nation, pharmaceutical industry and enterprises; and offering consultations for China's decision makers. Its role will be to promote the establishment of a scientific, rational and strict pharmaceutical IP rights system to support pharmaceutical innovation; provide advice for the industry and government by initiating research on TCM IP rights in international trading; and groom technical expertise in a planned and systematic way. (Click here for more - Chinese language)